Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News InspireMD Inc NSPR

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:NSPR)

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 3, 2024

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

GlobeNewswire March 26, 2024

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

GlobeNewswire March 6, 2024

InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th

GlobeNewswire February 28, 2024

InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard(TM) Neuroprotection System

GlobeNewswire February 12, 2024

InspireMD Receives CE Mark Recertification Under EU's New Medical Device Regulation (MDR) Regulatory Framework

GlobeNewswire January 31, 2024

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

GlobeNewswire January 3, 2024

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard(TM) Neuroprotection System

GlobeNewswire December 20, 2023

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

GlobeNewswire November 27, 2023

Opinion & Analysis (NDAQ:NSPR)

No current opinion is available.

Bullboard Posts (NDAQ:NSPR)

RE:RE:it's a buy today for me

If you look at a Linc presentation on the different covered stents then you will find that Inspiremd has a very unique offering with...
dmacd - February 19, 2019

RE:it's a buy today for me

Added more today .. the LINC sessions will drive up the SP ... my expectation anyways. Had to average down after the dilutive financing...
dmacd - January 22, 2019

it's a buy today for me

got in big time here,I was bargain hunting and I saw the conference in california was a success,so it was easy to see a breakout in the...
coolfooldumbguy - October 18, 2018

What is up?

Anyone have thoughts on why this dropped from a high of 28.50 this year? Looks like we are at bargain levels to me. Particularly the...
7Twiggy - November 5, 2016